cis-4-((tert-Butoxycarbonyl)amino)cyclohexanecarboxylic acid, 97.0%, 250mg

(1R)-6-Fluoro-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride, 97%, 250mg

2,6-Dichloro-4-(hydroxymethyl)phenol, 97%, 100mg

Fmoc-6-Ahx-OH>95.0%(HPLC)(T)25g

5-Methoxy-1-benzofuran-3(2H)-one, 95.0%, 1g

1-(PYRAZIN-2-YL)CYCLOPROPANAMINE HCL, 95.0%, 100mg

3',4'-Dichlorodiphenylether, 1g

(4-Bromo-phenyl)-diphenyl-amine, 97.0%, 5g

6-CHLORO-3-IODOIMIDAZO[1,2-A]PYRAZINE, 95.0%, 10g

GC capillary column ROTI®Cap-1, 15 m, 0.53 mm, 1.00 µm, 1 Piece(s)

8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione, 95.0%, 10g

4-(2,3-Dimethoxybenzoyl)isoquinoline, 97.0%, 1g

2-AMINO-7,8-DIHYDROQUINAZOLIN-5-ONE, 97.0%, 25g